Prophylactic activity of orally administered dry-heat-sterilized Acremonium egyptiacum against Trypanosoma congolense- induced animal African trypanosomosis

Ai Yamazaki,Yusuke Tanaka,Kenichi Watanabe,Mayu Sato,Shin-ichiro Kawazu,Kiyoshi Kita,Noboru Inoue,Helena D. Janse van Rensburg,David D. N'Da,Keisuke Suganuma
DOI: https://doi.org/10.1016/j.actatropica.2024.107185
IF: 3.222
2024-03-18
Acta Tropica
Abstract:Animal African trypanosomosis (AAT) is an important global disease of livestock that causes economic losses of up to 4.5 billion US dollars per year. Thus, eliminating AAT in endemic countries will improve agricultural productivity and economic growth. To prevent AAT, vector control and the development of prophylactic drugs are crucial. Ascofuranone (AF) is a bioactive fungal compound with proven in vitro trypanocidal potency and in vivo treatment efficacy. However, the complex stereoselective synthesis of AF has prevented its cost-effective industrial production. Recently, a genetically modified strain of Acremonium egyptiacum fungus that produces a high yield of AF was developed. Therefore, we hypothesized that the oral administration of the AF-producing fungus itself may be effective against AAT. Hence, this study aimed to evaluate the prophylactic activity of orally administered dry-heat-sterilized A. egyptiacum against Trypanosoma congolense IL3000 infection using a mouse model. The survival rate was significantly prolonged ( p = 0.009), and parasitemia was suppressed in all AF-fungus-treated groups (Group 1–9) compared with that in the untreated control group (Group 10). Hence, the trypanocidal activity of AF was retained after dry-heat-sterilization of the AF-producing fungus and that its oral administration effectively prevented AAT. Since AAT is endemic to rural areas with underdeveloped veterinary infrastructure, dry-heat-sterilized A. egyptiacum would be the most cost-effective potential treatment for AAT.
tropical medicine,parasitology
What problem does this paper attempt to address?